Trial Condition(s):

Diagnostic Imaging, Heart Defects, Congenital

Dose finding study with SH U 454 as an echocardiographic contrast agent for clarification of congenital malformations involving the right heart in patients from 0 - 18 years

Bayer Identifier:

Trial_85236

ClinicalTrials.gov Identifier:

Not Available

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Please see attached Study Results Summary below.

Inclusion Criteria
No Inclusion Criteria Available
Exclusion Criteria
No Exclusion Criteria Available

Trial Summary

Enrollment Goal
49
Trial Dates
black-arrow
Phase
3
Could I receive a placebo?
No
Products
Echovist (α-D-Galactose, BAY86-4872)
Accepts Healthy Volunteers
N/A

Where to Participate

Locations
Status
LocationsStatus

For details, please refer to trial results

Additional Information